UPDATED Feb 06, 2024
Online and catalog retail companies worldwide.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
6622Zhaoke Ophthalmology | HK$1.79 | -40.1% | -67.5% | HK$977.6m | HK$6.75 | PS78.7x | E49.1% | n/a | ||
8049Jilin Province Huinan Changlong Bio-pharmacy | HK$1.70 | 0% | 44.1% | HK$952.4m | n/a | PE3.9x | n/a | 32.3% | ||
6118Austar Lifesciences | HK$1.69 | -11.1% | -19.9% | HK$866.3m | n/a | PE470.7x | n/a | 0% | ||
6996Antengene | HK$1.27 | -1.6% | -74.6% | HK$857.1m | HK$4.26 | PS4.4x | E12.3% | n/a | ||
950Lee's Pharmaceutical Holdings | HK$1.41 | 2.2% | -29.1% | HK$830.3m | HK$1.00 | PE21.3x | S13.5% | 1.1% | ||
2161JBM (Healthcare) | HK$0.96 | 0% | 18.5% | HK$795.2m | n/a | PE8.1x | n/a | 7.2% | ||
2126JW (Cayman) Therapeutics | HK$1.89 | 12.5% | -63.4% | HK$759.0m | HK$3.05 | PS4.1x | E28.6% | n/a | ||
503Lansen Pharmaceutical Holdings | HK$1.79 | 0% | 23.6% | HK$750.6m | n/a | PE13x | n/a | 2.7% | ||
9939Kintor Pharmaceutical | HK$1.66 | 37.2% | -83.9% | HK$742.8m | HK$14.51 | PB0.5x | E4.0% | n/a | ||
2197Clover Biopharmaceuticals | HK$0.43 | -1.1% | -82.7% | HK$563.9m | n/a | PS1995.5x | n/a | n/a | ||
690Uni-Bio Science Group | HK$0.09 | -7.2% | 55.2% | HK$554.7m | n/a | PE8.8x | n/a | n/a | ||
239Pak Fah Yeow International | HK$1.78 | 0% | 41.3% | HK$554.7m | n/a | PE6.3x | n/a | 6.9% | ||
897Wai Yuen Tong Medicine Holdings | HK$0.41 | -2.4% | 26.2% | HK$480.2m | n/a | PE13.2x | n/a | 0% | ||
6998Genor Biopharma Holdings | HK$0.93 | 2.2% | -69.4% | HK$468.8m | n/a | PS32.9x | n/a | n/a | ||
455Tianda Pharmaceuticals | HK$0.19 | -11.4% | -33.6% | HK$399.9m | n/a | PB0.6x | n/a | 1.4% | ||
1498PuraPharm | HK$0.81 | -3.6% | -31.9% | HK$320.0m | n/a | PB1.5x | n/a | 0% | ||
8329Shenzhen Neptunus Interlong Bio-technique | HK$0.15 | -1.9% | -6.2% | HK$253.4m | n/a | PE3.6x | n/a | n/a | ||
1643Modern Chinese Medicine Group | HK$0.31 | -3.1% | -42.6% | HK$186.0m | n/a | PE2.6x | n/a | 0% | ||
1312Kontafarma China Holdings | HK$0.032 | -5.9% | -36.0% | HK$178.8m | n/a | PE33x | n/a | 0% | ||
1228CANbridge Pharmaceuticals | HK$0.41 | -4.7% | -81.4% | HK$174.1m | HK$8.85 | PS1.8x | E19.7% | n/a | ||
1889Sanai Health Industry Group | HK$0.049 | -2.0% | -49.5% | HK$157.3m | n/a | PE3.9x | n/a | 0% | ||
8225China Health Group | HK$0.15 | -10.3% | -47.1% | HK$147.3m | n/a | PS7.5x | n/a | n/a | ||
8158China Regenerative Medicine International | HK$0.47 | 3.3% | -61.2% | HK$143.0m | n/a | PE211.2x | n/a | n/a | ||
1011China NT Pharma Group | HK$0.044 | 29.4% | -50.0% | HK$116.2m | n/a | PE-2.4x | n/a | 0% |